Pharmacy Compounding Accreditation Board Set Up By Trade Groups
This article was originally published in The Pink Sheet Daily
Executive Summary
The initial focus will be on sterile compounding in the community practice setting. Accreditation of sites could begin by the end of the year.
You may also be interested in...
Sterile Product Recalls Reflect FDA Inspection Priorities
Drug recalls for 2003 included a significant number of cases involving microbial contamination of injectable products. Counterfeit versions of products resulted in four of the 181 recalls during the year.
Pink Sheet Podcast: Relyvrio And Public Promises, Allergy Biomarker Adcomms, PMDA In The USA
Pink Sheet reporters and editor discuss the implications of Amylyx following through on its pledge to remove Relyvrio from the market after its trial failed, an FDA idea to bring potential biomarkers for promising allergy and asthma treatments to advisory committees, and Japan’s PMDA opening an office in Washington D.C.
Pink Sheet Podcast: Mifepristone And Misinformation At SCOTUS, Understanding US FDA’s ODAC
Pink Sheet reporters and editor discuss the upcoming US Supreme Court arguments on mifepristone access, the SCOTUS reaction to the fight against misinformation, and the FDA’s Oncologic Drugs Advisory Committee going against three negative product reviews.